2-guanidino-4-(2-methyl-4-imidazolyl)thiazoles in the treatment of rheumatoid arthritis
US4591595A · kind A · utility
0Cited by
1References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 9, 1985 |
| Grant date | May 27, 1986 |
| Priority date | — |
| Expiry date | Aug 9, 2005 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/425
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
2-Guanidino-4-(2-methyl-4-imidazolyl)thiazole and 2-(N-pentyl-N'-guanidino)-4-(2-methyl-4-imidazolyl)thiazole, histamine-H.sub.2 antagonist useful as a gastric acid antisecretory and antiulcer agents, are also useful per se in the treatment of rheumatoid arthritis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.